Responses
Other responses
Jump to comment:
- Published on: 30 March 2011
- Published on: 7 February 2011
- Published on: 30 March 2011Author Response Re: "Need to further investigate the efficacy of valproic acid therapy in retinal degenerative disorders" letterShow More
Dear Editor,
We appreciate the interest of Dr. Kahn and Dr. Philip [1] in our paper describing pilot results from a retrospective study in patients with retinitis pigmentosa (RP) treated with valproic acid (VPA) [2], and we would like to comment on the points raised by them.
Length of treatment. As mentioned in our recent reply to another letter regarding the same article [3], the length of treatment...
Conflict of Interest:
None declared. - Published on: 7 February 2011Need to further investigate the efficacy of valproic acid therapy in retinal degenerative disordersShow More
Dear Editor,
We have a few concerns on the report by Clemson CM et al on the efficacy of valproic acid (VPA) in 7 patients with retinitis pigmentosa (RP) [1]. Was the time period of 6 months for using VPA the maximum time that was allowed by the institutional review boards? The degree to which the retina was affected by RP was not mentioned in each case (either in the form of photographic evidence or by electro...
Conflict of Interest:
None declared.